色噜噜人体337p人体 I 超碰97观看 I 91久久香蕉国产日韩欧美9色 I 色婷婷我要去我去也 I 日本午夜a I 国产av高清怡春院 I 桃色精品 I 91香蕉国产 I 另类小说第一页 I 日操夜夜操 I 久久性色 I 日韩欧在线 I 国产深夜在线观看 I 免费的av I 18在线观看视频 I 他也色在线视频 I 亚洲熟女中文字幕男人总站 I 亚洲国产综合精品中文第一 I 人妻丰满熟av无码区hd I 新黄色网址 I 国产精品真实灌醉女在线播放 I 欧美巨大荫蒂茸毛毛人妖 I 国产一区欧美 I 欧洲亚洲1卡二卡三卡2021 I 国产亚洲欧美在线观看三区 I 97精品无人区乱码在线观看 I 欧美妇人 I 96精品在线视频 I 国产人免费视频在线观看 I 91麻豆国产福利在线观看

雅思閱讀模擬試題參考

時間:2021-06-10 19:14:49 試題 我要投稿

雅思閱讀模擬試題參考

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

雅思閱讀模擬試題參考

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

  Under pressure

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap.

  Going up

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

  (613 words nature)

  Questions 1-7

  This passage has 7 paragraphs 1-7.

  Choose the correct heading for each paragraph from the list of headings below.

  Write the correct number i-ix in boxes 1-7 on your answer sheet.

  List of Headings

  i. How does torcetrapib work?

  ii. Contradictory result prior to the current trial

  iii. One failure may possibly bring about future success

  iv. The failure doesn’t lead to total loss of confidence

  v. It is the right route to follow

  vi. Why it’s stopped

  vii. They may combine and theoretically produce ideal result

  viii. What’s wrong with the drug

  ix. It might be wrong at the first place

  Example answer

  Paragraph 1 iv

  1. Paragraph 2

  2. Paragraph 3

  3. Paragraph 4

  4. Paragraph 5

  5. Paragraph 6

  6. Paragraph 7

  Questions 7-13

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

  NB You may use any letter more than once.

  7.It has been administered to over 10,000 subjects in a clinical trial.

  8.It could help rid human body of cholesterol.

  9.Researchers are yet to find more about it.

  10. It was used to reduce the level of cholesterol.

  11. According to Kashyap, it might lead to unwanted result if it’s blocked.

  12. It produced contradictory results in different trials.

  13. It could inhibit LDLs.

  List of choices

  A. Torcetrapic

  B. HDLS

  C. Statin

  D. CETP

  (by Zhou Hong)

  Suggested Answers and Explanations

  1. vi

  2. ii

  3. vii 本段介紹了torcetrapib和statin的治病原理,但是同時短語in contrast與之前第二段后半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。

  4. iii 本段分析了可能導致torcetrapibl臨床試驗失敗的原因,后半段指出如果以上推測正確,那么未來的藥物可借鑒這個試驗,設法避免torcetrapib的缺陷,研制出有效的'藥物。viii選項無法涵蓋后半段的意思。

  5. ix 見首句。

  6. v

  7. A 見第二段。題目中administer一詞意為用藥,subject一詞為實驗對象之意。

  8. B 見第四段… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最終是將 choleserol清除出人體:… for removal from the body。

  9. B 見第四段But HDLs are complex and not entirely understood.

  10. C 見第二段… plus a cholesterol-lowering statin,即statin是可以降低cholesterol的。

  11. D 見第六段 So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

  12. A 見第三段。

  13. C 見第四段Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

【雅思閱讀模擬試題參考】相關文章:

雅思歷年閱讀模擬試題04-01

雅思閱讀模擬練習試題及答案11-26

雅思模擬閱讀習題06-14

雅思聽力模擬試題練習03-19

科學模擬試題參考06-11

模擬試題及答案參考06-13

雅思閱讀模擬練習題06-14

雅思閱讀經典模擬題06-13

關于雅思閱讀模擬習題及答案12-27

主站蜘蛛池模板: 亚洲 欧美 清纯 校园 另类 | 国产色视频网站 | 91干| 91porny九色肥婆 | 色偷偷色噜噜狠狠成人免费视频 | 亚洲字幕成人中文在线电影网 | 国产精品18久久久久久麻辣 | 内射白嫩少妇超碰 | 久久人妻少妇嫩草av蜜桃 | 一级a毛片 | 丰满饥渴老女人hd | 中文字幕乱码久久午夜 | 精品亚洲国产成人小电影 | 午夜福利伦伦电影理论片在线观看 | 三级成年网站在线观看级爱网 | 午夜精品一区二区三区在线视频 | 九九久久精品无码专区 | 久久午夜夜伦鲁鲁片免费无码影院 | 久久天天躁狠狠躁夜夜不卡 | 欧亚毛片| 亚洲色欲色欲www在线播放 | 久操视频免费 | 亚洲情趣视频 | 91精品久久久久久蜜桃 | 伊人色区 | 色七七桃花影院 | 97久久国产露脸精品国产 | 狠狠色噜噜狠狠狠狠97俺也去 | 日韩免费视频一一二区 | 日韩中文字幕在线视频 | 婷婷六月天综合 | 高h喷水荡肉爽文np肉色学校 | 四虎精品免费永久免费视频 | 成人精品一区二区三区网站 | 亚洲三区精品 | 操一操av| 欧美成人精品欧美一级乱 | 爱爱网站视频 | 五十六十日本老熟妇乱 | 2020国产亚洲美女精品久久久 | 五月激情在线观看 | 99精品国产在热久久无毒 | 国产成人黄色在线 | 亚洲最新视频 | 窝窝午夜理论片影院 | 粉嫩一区二区三区粉嫩视频 | 亚洲热视频在线观看 | 精品深夜av无码一区二区老年 | 亚洲精品国产偷自在线观看 | 国产重口老太伦 | 免费观看全黄做爰的视频 | 成人情侣激情偷拍视频 | 看免费真人视频网站 | 国产精品国产三级国产av主播 | 国产又猛又黄又爽 | 亚洲欧美国产国产一区 | 中文字幕+乱码+中文乱码www | 日韩欧美一区二 | 久久婷婷影视 | 天堂网在线播放 | 99精美视频 | 99福利视频 | 夜夜爽狠狠天天婷婷五月 | 国产永久在线 | 99热最新精品 | 久久精品国产99国产精2021 | 亚洲综合无码一区二区三区不卡 | 99精品久久久久久久久久综合 | 丰满人妻av无码一区二区三区 | 国产高清在线观看 | av免费在线观看网站 | 乱lun合集在线观看视频 | 97碰成人国产免费公开视频 | 国产福利合集 | 欧美日韩国产色综合视频 | 伊人第一页 | 免费无码不卡视频在线观看 | 肉嫁高柳家在线 | 粗大挺进尤物人妻中文字幕 | 国产萌白酱喷水视频在线观看 | 特黄视频在线观看 | 亚洲国产日韩综合久久精品 | 最色视频 | 国产av永久无码精品网站 | 午夜剧场一级片 | 老熟女高潮喷水了 | 国模精品一区 | av女优天堂 | 国产aaaaav久久久一区二区 | 中中文字幕亚洲无线码 | av毛片国产 | 加勒比东京热无码一区 | 无码人妻在线一区二区三区免费 | 欧美日韩在线视频观看 | 五月花激情 | aaa一级黄色片 | 伊人黄网 | 久久久久亚洲精品天堂 | 亚洲成av人影院在线观看 |